The risk of premalignant and malignant pathology in endomentrial polyps: Should every polyp be resected?

A. Papadia, D. Gerbaldo, E. Fulcheri, N. Ragni, S. Menoni, S. Zanardi, B. Brusacà

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Aim. There is no wide consensus in the literature on the clinical significance and management of symptomatic and asymptomatic polyps. Aims of the study are to evaluate frequency of premalignant and malignant histopathologic features in endometrial polyps resected hysteroscopically and identify clinical parameters able to predict final histopathologic diagnosis. Methods. Clinical data and pathologic report of 90 consecutive operative hysteroscopies performed on women with endometrial polyps were collected. Frequency of premalignant and malignant histopathologic features on the polyps were calculated and relation to clinical risk factors analyzed. Results. The frequency of premalignant and malignant histopathologic features in polyps was 6.7% and 2.2% respectively. Owing to the small sample size no statistical analysis to detect clinical risk factor for premalignant or malignant histopathologic features could be performed. Conclusion. Frequency of premalignant and malignant histopathologic features in symptomatic and asymptomatic patients is not negligible. Reported clinical risk factors for malignant degeneration of endometrial polypoid lesions are the same as those reported for endometrial cancer and are very common in patients with endometrial polyps. Every endometrial polyp should be resected.

Original languageEnglish
Pages (from-to)117-124
Number of pages8
JournalMinerva Ginecologica
Volume59
Issue number2
Publication statusPublished - Apr 2007

Fingerprint

Polyps
Pathology
Hysteroscopy
Endometrial Neoplasms
Sample Size

Keywords

  • Endometrial cancer
  • Endometrial hyperplasia
  • Hysteroscopy
  • Polyps

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Papadia, A., Gerbaldo, D., Fulcheri, E., Ragni, N., Menoni, S., Zanardi, S., & Brusacà, B. (2007). The risk of premalignant and malignant pathology in endomentrial polyps: Should every polyp be resected? Minerva Ginecologica, 59(2), 117-124.

The risk of premalignant and malignant pathology in endomentrial polyps : Should every polyp be resected? / Papadia, A.; Gerbaldo, D.; Fulcheri, E.; Ragni, N.; Menoni, S.; Zanardi, S.; Brusacà, B.

In: Minerva Ginecologica, Vol. 59, No. 2, 04.2007, p. 117-124.

Research output: Contribution to journalArticle

Papadia, A, Gerbaldo, D, Fulcheri, E, Ragni, N, Menoni, S, Zanardi, S & Brusacà, B 2007, 'The risk of premalignant and malignant pathology in endomentrial polyps: Should every polyp be resected?', Minerva Ginecologica, vol. 59, no. 2, pp. 117-124.
Papadia, A. ; Gerbaldo, D. ; Fulcheri, E. ; Ragni, N. ; Menoni, S. ; Zanardi, S. ; Brusacà, B. / The risk of premalignant and malignant pathology in endomentrial polyps : Should every polyp be resected?. In: Minerva Ginecologica. 2007 ; Vol. 59, No. 2. pp. 117-124.
@article{66eb09be08874c2dbf5715649127c664,
title = "The risk of premalignant and malignant pathology in endomentrial polyps: Should every polyp be resected?",
abstract = "Aim. There is no wide consensus in the literature on the clinical significance and management of symptomatic and asymptomatic polyps. Aims of the study are to evaluate frequency of premalignant and malignant histopathologic features in endometrial polyps resected hysteroscopically and identify clinical parameters able to predict final histopathologic diagnosis. Methods. Clinical data and pathologic report of 90 consecutive operative hysteroscopies performed on women with endometrial polyps were collected. Frequency of premalignant and malignant histopathologic features on the polyps were calculated and relation to clinical risk factors analyzed. Results. The frequency of premalignant and malignant histopathologic features in polyps was 6.7{\%} and 2.2{\%} respectively. Owing to the small sample size no statistical analysis to detect clinical risk factor for premalignant or malignant histopathologic features could be performed. Conclusion. Frequency of premalignant and malignant histopathologic features in symptomatic and asymptomatic patients is not negligible. Reported clinical risk factors for malignant degeneration of endometrial polypoid lesions are the same as those reported for endometrial cancer and are very common in patients with endometrial polyps. Every endometrial polyp should be resected.",
keywords = "Endometrial cancer, Endometrial hyperplasia, Hysteroscopy, Polyps",
author = "A. Papadia and D. Gerbaldo and E. Fulcheri and N. Ragni and S. Menoni and S. Zanardi and B. Brusac{\`a}",
year = "2007",
month = "4",
language = "English",
volume = "59",
pages = "117--124",
journal = "Minerva Ginecologica",
issn = "0026-4784",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - The risk of premalignant and malignant pathology in endomentrial polyps

T2 - Should every polyp be resected?

AU - Papadia, A.

AU - Gerbaldo, D.

AU - Fulcheri, E.

AU - Ragni, N.

AU - Menoni, S.

AU - Zanardi, S.

AU - Brusacà, B.

PY - 2007/4

Y1 - 2007/4

N2 - Aim. There is no wide consensus in the literature on the clinical significance and management of symptomatic and asymptomatic polyps. Aims of the study are to evaluate frequency of premalignant and malignant histopathologic features in endometrial polyps resected hysteroscopically and identify clinical parameters able to predict final histopathologic diagnosis. Methods. Clinical data and pathologic report of 90 consecutive operative hysteroscopies performed on women with endometrial polyps were collected. Frequency of premalignant and malignant histopathologic features on the polyps were calculated and relation to clinical risk factors analyzed. Results. The frequency of premalignant and malignant histopathologic features in polyps was 6.7% and 2.2% respectively. Owing to the small sample size no statistical analysis to detect clinical risk factor for premalignant or malignant histopathologic features could be performed. Conclusion. Frequency of premalignant and malignant histopathologic features in symptomatic and asymptomatic patients is not negligible. Reported clinical risk factors for malignant degeneration of endometrial polypoid lesions are the same as those reported for endometrial cancer and are very common in patients with endometrial polyps. Every endometrial polyp should be resected.

AB - Aim. There is no wide consensus in the literature on the clinical significance and management of symptomatic and asymptomatic polyps. Aims of the study are to evaluate frequency of premalignant and malignant histopathologic features in endometrial polyps resected hysteroscopically and identify clinical parameters able to predict final histopathologic diagnosis. Methods. Clinical data and pathologic report of 90 consecutive operative hysteroscopies performed on women with endometrial polyps were collected. Frequency of premalignant and malignant histopathologic features on the polyps were calculated and relation to clinical risk factors analyzed. Results. The frequency of premalignant and malignant histopathologic features in polyps was 6.7% and 2.2% respectively. Owing to the small sample size no statistical analysis to detect clinical risk factor for premalignant or malignant histopathologic features could be performed. Conclusion. Frequency of premalignant and malignant histopathologic features in symptomatic and asymptomatic patients is not negligible. Reported clinical risk factors for malignant degeneration of endometrial polypoid lesions are the same as those reported for endometrial cancer and are very common in patients with endometrial polyps. Every endometrial polyp should be resected.

KW - Endometrial cancer

KW - Endometrial hyperplasia

KW - Hysteroscopy

KW - Polyps

UR - http://www.scopus.com/inward/record.url?scp=34447520464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447520464&partnerID=8YFLogxK

M3 - Article

C2 - 17505453

AN - SCOPUS:34447520464

VL - 59

SP - 117

EP - 124

JO - Minerva Ginecologica

JF - Minerva Ginecologica

SN - 0026-4784

IS - 2

ER -